Key points for investors:
- Operational wins & backlog: Lockheed announced a $1.5 billion direct commercial sale of 12 Block 70 F-16s to Peru (with potential for 12 more) and highlighted continued strong operational performance of core platforms (F-35, F-22, PAC-3/THAAD, Black Hawk, C-130, Orion/Artemis). Orion successfully supported Artemis 2, reinforcing Lockheed's role in deep-space exploration and follow-on Artemis missions.
- Munitions acceleration & production ramp: The company secured large PAC-3 awards (including a $4.8 billion fully funded undefinitized contract and a $2.2 billion award in Q1) and described multiyear framework agreements to scale production (3x–4x for PAC-3/THAAD and other munitions). Lockheed plans >20 facility investments and supplier second/third source development to support higher rates, with government co-investment and contract provisions to mitigate risk.
- Financial results: Q1 sales of $18.0B were flat vs. prior year (impacted by a shortened fiscal period); segment operating profit was $1.8B (down YoY) and EPS was $6.44 (down ~12%), driven by lower profit, mark-to-market losses, and prior-year nonrecurring benefits. Notable program headwinds included unfavorable profit adjustments on F-16 and C-130 (design/integration/supplier timing), and adverse impacts in parts of RMS. Free cash flow used $291M in Q1 (working capital timing and an ERP implementation); the company paid $816M dividends and retired $1B debt. CapEx was $511M and R&D $458M in Q1.
- Guidance & capital allocation: Management reiterated full-year 2026 guidance: mid-single-digit sales growth; operating profit $8.4B–$8.7B; free cash flow $6.5B–$6.8B; and CapEx expectation of $2.5B–$2.8B (higher due to production ramp investments). They expect margins and cash flow to improve in H2 as production milestones are achieved.
- Strategy & investments: Continued emphasis on scaling production speed and resiliency, digital transformation (AI, model-based engineering, open architectures), expanding the Lockheed Martin Venture Fund to $1B, and strategic investments/partnerships (including a counter-UAS solution). Workforce development and facility expansion (e.g., Camden, AR munitions center) are key priorities.
- Risks & near-term issues: Execution and supply-chain risks remain on some Aeronautics (F-16 rework flight-test delays; resumed deliveries) and C-130 lines, a classified program with remaining complexity (no new charges this quarter but under increased executive oversight), ERP-related working capital timing, and near-term margin volatility due to prior-year nonrecurring items. Management describes contractual risk-mitigation (advanced payments, NRE allocations, inflation indexing, clawback protections) with the U.S. government to limit downside from accelerated production commitments.
Sign In
Buy LMT
